Only 1 participant (participant 3) with HPV-mediated HNSCC had 2 frameshift mutations identified in HLA-A (HLA-A* 68010102) (Supplemental Table 7), which may explain the lack of clinical and molecular response in this participant. This evidence concerns the gene HLA-A and head and neck squamous cell carcinoma.